In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
January 22nd, 2020
5K views
Here we present a protocol for in vivo augmentation of gut-homing regulatory T cell induction. In this protocol, dendritic cells are engineered to locally produce high concentrations of the active vitamin D (1,25-dihydroxyvitamin D or 1,25[OH]2D) and the active vitamin A (retinoic acid or RA) de novo.
Overview
This protocol describes a novel therapeutic strategy for enhancing gut-homing regulatory T cell induction through engineered dendritic cells. It can be adapted for human applications and is effective in pro-inflammatory environments.
Key Study Components
Area of Science
- Immunology
- Cell Biology
- Therapeutic Strategies
Background
- Regulatory T cells play a crucial role in maintaining immune homeostasis.
- Active vitamin D and vitamin A are important for immune system function.
- Engineering dendritic cells can enhance T cell responses.
- This protocol aims to improve the understanding of vitamin roles in immunity.
Purpose of Study
- To develop a protocol for the induction of gut-homing regulatory T cells.
- To explore the effects of active vitamin D and A on the immune system.
- To provide a method that can be used in highly inflammatory conditions.
Methods Used
- Seeding 293T cells in cell culture medium.
- Using concentrated HBS solution and plasmids for dendritic cell engineering.
- Incubation at controlled temperature and CO2 levels.
- Step-by-step visual demonstration of the protocol.
Main Results
- Successful generation of engineered dendritic cells.
- Enhanced induction of gut-homing regulatory T cells observed.
- Protocol applicable in various inflammatory contexts.
- Insights into the role of vitamins in immune modulation.
Conclusions
- The protocol offers a promising approach for T cell induction.
- Engineering dendritic cells can be a valuable tool in immunotherapy.
- Further research is needed to explore clinical applications.
Frequently Asked Questions
What are gut-homing regulatory T cells?
Gut-homing regulatory T cells are specialized immune cells that help maintain tolerance and prevent inflammation in the gut.
How does vitamin D influence the immune system?
Vitamin D plays a role in modulating immune responses and enhancing the function of regulatory T cells.
Can this protocol be used in human applications?
Yes, the protocol is designed to be adaptable for potential human therapeutic applications.
What is the significance of dendritic cells in immunity?
Dendritic cells are key antigen-presenting cells that initiate and regulate immune responses.
What are the conditions for cell culture in this protocol?
Cells are cultured at 37 degrees Celsius with 5% CO2 for optimal growth.
What role does retinoic acid play in T cell induction?
Retinoic acid is involved in the differentiation and migration of T cells to the gut.
Executive Industry Relevance
Augmenting gut-homing regulatory T cell induction addresses a critical bottleneck in immune modulation for inflammatory bowel disease and related disorders. This protocol enables precise in vivo manipulation of immune cell trafficking and function, supporting predictive confidence in early-stage immunology pipelines. The approach offers a reusable platform for mechanistic de-risking and target validation in immune-mediated disease portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of immune regulatory pathways relevant to mucosal tolerance.
- Supports functional validation of vitamin D and A metabolic targets in immune cell engineering.
- Facilitates mechanistic de-risking by isolating the effects of engineered dendritic cells on Treg induction.
- Provides a platform for hypothesis-driven evaluation of immune cell trafficking mechanisms.
Screening & Assay Development
- Establishes validated immune cell systems for downstream functional assays.
- Enables quantitative measurement of Treg induction and gut-homing marker expression.
- Supports reproducible generation of engineered dendritic cells for assay standardization.
- Prepares scalable workflows for compound or genetic screening targeting immune modulation.
Translational & Preclinical Research
- Aligns with disease-relevant models for mucosal immunology and IBD research.
- Enables continuity from in vitro immune modulation to in vivo functional validation.
- Supports risk-adjusted advancement of immune-targeted therapeutic strategies.
- Provides translational insight into the role of micronutrients in immune regulation.
Pipeline & Workflow Integration
This protocol integrates into the discovery-to-preclinical continuum for immune modulation, bridging early mechanistic studies with in vivo validation of therapeutic hypotheses.
- Discovery Biology: Supports hypothesis testing on the role of engineered dendritic cells in Treg induction and trafficking.
- Screening: Delivers reproducible, quantitative outputs for immune cell function and marker expression.
- Analytics: Enables statistical comparison of Treg induction across engineered and control conditions.
- Translational Research: Connects in vitro findings to in vivo immune modulation in disease-relevant models.
- Enterprise Reuse: Provides a modular platform adaptable to diverse immune cell engineering applications.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in immune modulation strategies and target validation.
- Operational Value: Standardizes immune cell engineering and functional readouts for reproducibility.
- Strategic Value: Informs go/no-go decisions for immune-targeted assets and reduces late-stage biological risk.
- Portfolio Impact: Enables risk-adjusted prioritization of immune modulation programs.
Implementation Considerations
- Requires expertise in immune cell culture, genetic engineering, and flow cytometry.
- Demands access to viral vector production and advanced cell sorting infrastructure.
- Necessitates cross-team standardization of cell preparation and functional assays.
- Adaptation may be needed for different animal models or human translation.
- Success depends on healthy T cell preparation and precise DNA mixture formulation.
Biopharma FAQs
Why does null hypothesis testing matter for Treg induction analysis?
Null hypothesis testing ensures that observed increases in gut-homing regulatory T cells are statistically significant and not due to random variation, supporting robust target validation. This is critical for de-risking early immune modulation strategies and informing portfolio decisions.
How does independent variable isolation fit engineered dendritic cell workflows?
Isolating the effects of engineered dendritic cells allows teams to attribute changes in Treg induction specifically to vitamin D and A pathway modulation. This clarity is essential for mechanistic de-risking and advancing immune engineering platforms.
What do quantitative measurements of Foxp3+CCR9+ T cells enable?
Quantitative assessment of Foxp3+CCR9+ CD4+ T cells provides actionable data on the efficiency of gut-homing Treg induction, enabling comparison across experimental conditions and supporting data-driven advancement decisions.
Why are replication requirements critical for cross-functional immune studies?
Replication ensures that Treg induction results are reproducible across teams and experiments, facilitating cross-functional collaboration and standardization in immune modulation research pipelines.
Which statistical analysis capabilities are required before immune protocol implementation?
Robust statistical analysis, including significance testing and quantitative comparison of Treg induction, is required to validate findings and support confident progression of immune engineering protocols in R&D workflows.
Chapters in this video
0:05
Title
0:57
1-alpha-Hydroxylase and Retinaldehyde Dehydrogenase 2 (RALDH2) Lentivirus (Lenti-CYP-ALDH virus) Preparation
3:04
Bone Marrow-Derived Dendritic Cell (BMDC) Generation
5:06
BMDC Lenti-CYP-ALDH Transduction
6:00
Results: Representative Gut-Homing Regulatory T Cell Induction
7:38
Conclusion
